Cargando…

Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods

In this study, the minimal residual disease (MRD) levels in patients with multiple myeloma (MM) were assessed by comparing the new 8-color single-tube multiparameter flow cytometry method (DuraClone), which reduces the cost of antibodies and labor burden of laboratories, with the EuroFlow next-gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoroidaka, Takeshi, Narita, Kentaro, Takamatsu, Hiroyuki, Fujisawa, Momoko, Nakao, Shinji, Matsue, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160149/ https://www.ncbi.nlm.nih.gov/pubmed/34045494 http://dx.doi.org/10.1038/s41598-021-89761-9

Ejemplares similares

Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma
por: Urushihara, Ryota, et al.
Publicado: (2023)

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
por: Kalina, T, et al.
Publicado: (2012)

Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study
por: Brouwer, Nienke, et al.
Publicado: (2022)

EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine
por: van Dongen, J J M, et al.
Publicado: (2012)

EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System
por: van Dongen, Jacques J. M., et al.
Publicado: (2019)

EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children
por: Kalina, Tomas, et al.
Publicado: (2020)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
por: Narita, Kentaro, et al.
Publicado: (2021)

The EuroFlow PID Orientation Tube for Flow Cytometric Diagnostic Screening of Primary Immunodeficiencies of the Lymphoid System
por: van der Burg, Mirjam, et al.
Publicado: (2019)

Automated EuroFlow approach for standardized in-depth dissection of human circulating B-cells and plasma cells
por: Delgado, Alejandro H., et al.
Publicado: (2023)

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
por: Turner, Rose, et al.
Publicado: (2022)

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study
por: Verbeek, Martijn W. C., et al.
Publicado: (2021)

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
por: van Dongen, J J M, et al.
Publicado: (2012)

Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels
por: Sędek, Łukasz, et al.
Publicado: (2022)

Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT)
por: Ferreira-Facio, Cristiane de Sá, et al.
Publicado: (2021)

Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients—A EuroFlow Study
por: Bras, Anne E., et al.
Publicado: (2022)

Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach
por: Terao, Toshiki, et al.
Publicado: (2020)

Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study
por: Lhermitte, Ludovic, et al.
Publicado: (2020)

Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools
por: del Pino-Molina, Lucía, et al.
Publicado: (2021)

Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
por: Matarraz, Sergio, et al.
Publicado: (2023)

Commercial DURAClone panels for extending the repertoire of multicolour immunophenotypic panels in an academic flow cytometry laboratory in South Africa
por: Swart, Leanne, et al.
Publicado: (2022)

Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
por: Tsushima, Takafumi, et al.
Publicado: (2021)

CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis
por: Schilhabel, Anke, et al.
Publicado: (2022)

N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
por: Kobayashi, Hiroki, et al.
Publicado: (2020)

Age Distribution of Multiple Functionally Relevant Subsets of CD4+ T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube
por: Botafogo, Vitor, et al.
Publicado: (2020)

Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation
por: Takamatsu, H., et al.
Publicado: (2017)

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2022)

Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence
por: Kitadate, Akihiro, et al.
Publicado: (2021)

Oligoclonal bands in patients with multiple myeloma: Its emergence per se could not be translated to improved survival
por: Fujisawa, Manabu, et al.
Publicado: (2014)

Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance
por: Nishida, Yuki, et al.
Publicado: (2017)

Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects
por: Criado, Ignacio, et al.
Publicado: (2022)

Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2021)

Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia
por: Tsushima, Takafumi, et al.
Publicado: (2022)

La línea dura
por: Torre, Gerardo de la, 1938-
Publicado: (1971)

La dura espina
por: Rosso, Renzo, 1926-
Publicado: (1967)

Sarcoma of the Dura Mater
por: Pal, S. B.
Publicado: (1916)

Tumour of the Dura Mater
por: Moinet, F.
Publicado: (1876)

CSF-to-dura gateways
por: Thomas, Jean-Leon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_47k47t6sb0np8upa8j39st068j